Applied Therapeutics, Inc. (APLT): Volume dana dhuwit perusahaan

Fabless manufacturing and eco-friendly packaging optimize costs, which this chart on GURU.Markets illustrates through the company's cash asset dynamics. The value 0.01 reflects the latest metric reading. Stable revenues ensure a lack of competition in the rare pathology niche, while the proprietary aldose reductase inhibitor platform creates a closed clinical loop, firmly tying medical centers to Applied Therapeutics (APLT) drugs.
Applied Therapeutics Inc. - rincian analitis lan metrik utama (APLT)

Applied Therapeutics is currently funding final clinical trials and the launch of orphan drugs using existing reserves. The cash balance trend quantifies the burn rate, allowing investors to assess the business's autonomy horizon before revenue generation or the need for a secondary offering, where the growth of the safety cushion balances protection against funding deficits with the risk of inefficient capital allocation.